Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
67 participants
INTERVENTIONAL
2012-11-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Oral Nutrition Supplement in Thai Malnourished Patients
NCT03443557
Zinc Bioavailability From Amaranth-enriched Maize Tortillas
NCT02208609
Community Oral Nutrition Support Trial
NCT00515125
The Effect on Micronutrient Status of a Diet of 100% Huel
NCT04734938
Mineral and Enzyme Deficiency Diseases Associated With Nutritional Diseases in Society
NCT04669106
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interventional
Administration of 1 bottle of an oral nutritional supplement, Renutryl® Booster (600 kcal), during 28 days.
Oral nutritional supplement : Renutryl® Booster
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral nutritional supplement : Renutryl® Booster
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
AND :
* Weight loss above or equal to 5% in one month
* OR weight loss above or equal to 10% in 6 months
* OR BMI between 18 and 21
* OR albuminaemia between 30 and 35 g/L
* OR MNA-SF less or equal to 7
Exclusion Criteria
* Contraindication to oral nutrition
* Severe pathologies
* Inflammatory syndrome (CRP \> 30 mg/L)
* Severe dementia (Mini Mental Score \< 10)
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12.01.FR.NHS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.